Le Lézard
Classified in: Health
Subjects: CHI, LEG, AVO

Reps. Pallone and Shalala Introduce Comprehensive Legislation to Reverse E-Cigarette Epidemic and Drive Down Youth Tobacco Use


WASHINGTON, April 17, 2019 /PRNewswire/ -- The Campaign for Tobacco-Free Kids strongly supports the Reversing the Youth Tobacco Epidemic Act of 2019 being introduced by House Energy and Commerce Chairman Frank Pallone (D-NJ) and Rep. Donna Shalala (D-FL). This legislation provides the comprehensive strategy we need to reverse the youth e-cigarette epidemic that is sweeping across our country and to continue driving down youth tobacco use. We applaud Chairman Pallone and Rep. Shalala for their leadership in introducing this legislation.

Campaign for Tobacco-Free Kids logo. (PRNewsFoto/Campaign for Tobacco-Free Kids)

The bill's prohibition on flavored tobacco products that appeal to kids, including flavored e-cigarettes, flavored cigars and menthol cigarettes, is especially critical to stop tobacco companies from continuing to target and addict kids with enticing flavors. Flavored e-cigarettes have driven the youth epidemic. In addition, flavored cigars have proliferated in recent years and become popular with kids, and more than half of youth smokers ? including seven out of ten African-American youth smokers ? smoke menthol cigarettes. Prohibiting flavored tobacco products is one of the most important steps we can take to reverse the youth e-cigarette epidemic and continue reducing youth tobacco use.

In addition to prohibiting flavored tobacco products, this bill includes other strong provisions that can accelerate progress in reducing tobacco use and save lives. These provisions:

Flavored Tobacco Products

The bill's prohibition on flavored tobacco products is strongly supported by scientific evidence. There is conclusive evidence that flavors play a critical role in youth initiation and continued use of tobacco products. Flavors improve the taste and mask the harshness of tobacco products, making it easier for kids to try the product and ultimately become addicted. The vast majority of youth tobacco users report starting with a flavored product and that they use tobacco products "because they come in flavors I like." E-cigarettes are sold in more than 15,000 flavors, and flavored cigars make up more than half of the U.S. cigar market. These products come in flavors like gummy bear, cotton candy, cherry dynamite and mango that clearly appeal to kids.

Flavored products, especially Juul, have driven the skyrocketing youth e-cigarette epidemic, which is addicting a new generation of kids and threatens the enormous, decades-long progress our nation has made in reducing youth tobacco use. In 2018 alone, e-cigarette use increased by an alarming 78 percent among high school students and 48 percent among middle school students, according to the 2018 National Youth Tobacco Survey (NYTS). More than 3.6 million middle and high school students were e-cigarette users in 2018 ? an increase of 1.5 million in just one year.

Flavored cigars are also popular among youth. Cigars are especially popular among high school boys, who smoke cigars at about the same rate as cigarettes, and among African-American high school students, who smoke cigars at nearly three times the rate of cigarettes, according to the 2018 NYTS.  Bloomberg News recently documented how tobacco companies have targeted African-American teens with candy- and fruit-flavored cigars.

There is also more than enough evidence to ban the sale of menthol cigarettes. Menthol cools and numbs the throat and reduces the harshness of tobacco smoke, making menthol cigarettes more appealing for kids who are starting to smoking. Over half of youth smokers ages 12-17 ? and seven in ten African-American youth smokers ? use menthol cigarettes. A comprehensive FDA scientific analysis, issued in 2013, concluded that menthol cigarettes 1) increase smoking initiation and progression to regular smoking among youth and young adults; 2) increase nicotine dependence (addiction); and 3) reduce success in quitting smoking.

For decades, the tobacco industry has engaged in targeted marketing of menthol cigarettes to African Americans and to youth. The marketing and availability of menthol cigarettes is a likely contributor to the higher rates of tobacco-caused death and disease experienced by African Americans.

This evidence led the FDA, in November 2018, to announce that it would seek to ban menthol in combustible tobacco products, including cigarettes and cigars. But the FDA has yet to propose a rule to do so, underscoring the need for Congress to act. At the time of the November 2018 announcement, then FDA Commissioner Scott Gottlieb stated, "I believe these menthol-flavored products represent one of the most common and pernicious routes by which kids initiate on combustible cigarettes. The menthol serves to mask some of the unattractive features of smoking that might otherwise discourage a child from smoking. Moreover, I believe that menthol products disproportionately and adversely affect underserved communities. And as a matter of public health, they exacerbate troubling disparities in health related to race and socioeconomic status."

 

SOURCE Campaign for Tobacco-Free Kids


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: